Sample | R(min) | K(min) | Angle(°) | MA(mm) | CI |
|---|
Control | 2.21 ± 0.31a | 1.11 ± 0.21a | 74.39 ± 2.81a | 70.02 ± 1.44a | 4.568 ± 0.63a |
LPS | 3.29 ± 0.67b | 2.95 ± 1.31b | 56.679 ± 9.92b | 49.91 ± 7.47b | -0.65 ± 0.75b |
LPS + SAA (40 mg/kg) | 2.52 ± 0.52a | 1.59 ± 0.58a | 67.55 ± 6.03a | 61.48 ± 6.03c | 2.62 ± 1.68c |
- 40 mg/kg SAA was administered by i.p. injection 1 h after, and 15 mg/kg LPS was administered by intravenous infusion. 3 h after, blood was obtained, and the coagulation function was tested with thromboelastometry. Data were presented as the mean ± SD. n = 9 in the Control group, n = 11 in the LPS group, and n = 9 in the LPS + SAA (40 mg/kg) group. Statistical analysis used were ANOVA (P<0.05), letters marked between different groups, if one is the same, the difference is not significant; if they are all different, the difference is significant
